Cargando…
Back to the future: evolutionary biology reveals a key regulatory switch in neuroblastoma pathogenesis
While MYCN expression is an important contributing factor to heterogeneity in the natural history of neuroblastoma (NBL), a mechanistic understanding of this often mutationally quiet tumor has remained elusive. In this issue of the JCI, Weichert-Leahey and authors focused on the adrenergic and mesen...
Autores principales: | Wertman, Jaime N., Berman, Jason N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178827/ https://www.ncbi.nlm.nih.gov/pubmed/37183823 http://dx.doi.org/10.1172/JCI167824 |
Ejemplares similares
-
The future of cytotoxic therapy: selective cytotoxicity based on biology is the key
por: de Bono, Johann S, et al.
Publicado: (2003) -
Back to the Evolutionary Future
por: Vázquez, José
Publicado: (2012) -
Back to the Future for Dermatophyte Genomics
por: Rivera, Zeyana S., et al.
Publicado: (2012) -
Cyprinid herpesvirus 3 and its evolutionary future as a biological control agent for carp in Australia
por: McColl, Kenneth A., et al.
Publicado: (2016) -
Back to the future but better
por: Brewster, Luke
Publicado: (2020)